It also provides guidance to hospital blood banks that would like to produce it. As part of its efforts to gain wider acceptance for fibrin sealant, the Tissue Adhesion Center recently received a patent for a procedure using tissue adhesives to reduce femoral artery bleeding after catheterization for procedures such as angiograms. Because of the extensive expertise in using sealants across a large number of clinical specialties, the Tissue Adhesion Center is the logical site for clinical trials. As a result of this interest, the Tissue Adhesion Center is completely self-supporting. The Tissue Adhesion Center is also investigating other functions for sealants.
Surgical sealants is an exciting field that is continually evolving.
Nonetheless, researchers have only recently begun to delve into the mechanisms behind this disease. Because women with PCOS have irregular periods or miss them entirely, PCOS used to be considered primarily a fertility problem and was then treated with therapies designed to induce ovulation. There was no organized effort to uncover the underlying cause of these symptoms, which include excess facial hair, obesity, and high insulin levels, because PCOS was not considered life-threatening. Today researchers take PCOS much more seriously. We now know that PCOS is associated with a high incidence of diabetes and cardiovascular disease later in life as well as increased rates of uterine cancer.